BPCIA: How Long Is The Party, And Do I Have To Dance?
On March 6, 2015, the U.S. Food and Drug Administration licensed the first ever U.S. biosimilar drug, Sandoz's Zarxio, a version of Amgen's Neupogen (filgrastim). On March 19, the Northern District of...To view the full article, register now.
Already a subscriber? Click here to view full article